BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lüke F, Harrer DC, Menhart K, Wolff D, Holler E, Hellwig D, Herr W, Grube M, Vogelhuber M, Reichle A, Heudobler D. Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin's Disease. Front Pharmacol 2021;12:599561. [PMID: 34220492 DOI: 10.3389/fphar.2021.599561] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Heudobler D, Ghibelli L, Reichle A. Editorial: Anakoinosis for promoting tumor tissue editing: Novel therapeutic opportunities for establishing clinically relevant tumor control by targeting tumor plasticity. Front Oncol 2022;12:1005381. [DOI: 10.3389/fonc.2022.1005381] [Reference Citation Analysis]
2 Harrer DC, Jakob M, Vogelhuber M, Lüke F, Utpatel K, Corbacioglu S, Herr W, Reichle A, Heudobler D. Biomodulatory therapy induces durable remissions in multi-system Langerhans cell histiocytosis. Leuk Lymphoma 2022;:1-11. [PMID: 35819881 DOI: 10.1080/10428194.2022.2095627] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lüke F, Harrer DC, Pantziarka P, Pukrop T, Ghibelli L, Gerner C, Reichle A, Heudobler D. Drug Repurposing by Tumor Tissue Editing. Front Oncol 2022;12:900985. [DOI: 10.3389/fonc.2022.900985] [Reference Citation Analysis]
4 Corsi F, Capradossi F, Pelliccia A, Briganti S, Bruni E, Traversa E, Torino F, Reichle A, Ghibelli L. Apoptosis as Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate Cancer. Int J Mol Sci 2022;23:1152. [PMID: 35163077 DOI: 10.3390/ijms23031152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
5 Antineoplastics/etoricoxib/pioglitazone. Reactions Weekly 2021;1876:52-52. [DOI: 10.1007/s40278-021-03301-7] [Reference Citation Analysis]